期刊文献+

GO-QOL在Graves眼病患者放射治疗后生存质量评价中的作用 被引量:2

Quality of life of patients with Graves'ophthalopathy after irradiation
暂未订购
导出
摘要 目的:分析Graves眼病生存质量量表(GO-QOL),在Graves眼病患者放射治疗后生存质量评价中的作用。方法:选取1979-1999年在解放军总医院接受放疗的104例Graves眼病患者为研究对象,并于2004-2005年应用GO-QOL调查表对研究对象进行生存质量问卷调查并统计分析。结果:本次调查随访期为7.5~25.0年,共发出调查问卷104份,收回87份。GO-QOL中视觉功能和社会心理功能均有不同程度的降低,有55.2%的患者对于放射治疗后的疗效不满。结论:Graves眼病的放射治疗后许多患者在相当长时间内的生存质量并不令人满意,眼部症状及体征依然存在,进而影响患者身心健康,故放射治疗后的相关治疗、护理及心理干预极其重要。GO-QOL较为适合Graves眼病的临床研究工作,值得大力推广。 Objective:To evaluate the long-term effect of Graves’ ophthalopathy (GO) on health-related quality of life (HRQL) after irradiation. Methods:From 1979 to 1999, one hundred and four patients with GO received orbital irradiation. Between 2004 and 2005, these patients receive the GO-QOL Questionnaire, and their outcome was analyzed. Results:87 patients complete the Graves’ophthalmopathy Quality of Life questionnaire. Follow-up period was between 7.5 and 25 years. 55.2%of respondents felt that their eyes were still abnormal. Conclusion:Orbital irradiation is effective and safe, but GO has a marked negative effect on HRQL, even many years after irradiation. Symptoms and signs of GO apparently persist and patients keep having trouble with general physical function and negative psychosocial consequences. So aftercare is needed for these patients after orbital irradiation.
出处 《中国医学装备》 2014年第2期52-55,共4页 China Medical Equipment
关键词 GRAVES眼病 放射治疗 甲状腺相关性眼病生存质量量表 生存质量 Graves&#39 ophthalopathy Radiotherapy Graves&#39 ophthalmopathy quality of life questionnaire Quality of life
  • 相关文献

参考文献17

  • 1Viani GA,Boin AC,De Fendi LI. Radiation therapy for Graves'ophthalmopathy:a systematic review and meta-analysis of randomized controlled trials[J].{H}Arquivos Brasileiros de Oftalmologia,2012,(05):324-332.
  • 2Kouloulias V,Kouvaris J,Zygogianni A. Efficacy and toxicity of radiotherapy for Graves'ophthalmopathy:the University of Athens experience[J].Head Neck Oncol,2013,(02):12.
  • 3Tanda ML,Bartalena L. Efficacy and safety of orbital radiotherapy for graves'orbitopathy[J].{H}Journal of Clinical Endocrinology and Metabolism,2012,(11):3857-3865.
  • 4Terwee CB,Gerding MN,Dekker FW. Development of a disease specific quality of life questionnaire for patients with Graves' ophthalmopathy:the GO-QOL[J].{H}British Journal of Ophthalmology,1998,(07):773-779.
  • 5Terwee C,Wakelkamp I,Tan S. Long-term effects of Graves'ophthalmopathy on health-related quality of life[J].{H}European Journal of Endocrinology,2002,(06):751-757.
  • 6Terwee CB,Dekker FW,Mourits MP. Interpretation and validity of changes in scores on the Graves'ophthalmopathy quality of life questionnaire(GO-QOL)after different treatments[J].{H}Clinical Endocrinology(Oxford),2001,(03):391-398.
  • 7Park JJ,Sullivan TJ,Mortimer RH. Assessing quality of life in Australian patients with Graves'ophthalmopathy[J].{H}British Journal of Ophthalmology,2004,(01):75-78.
  • 8Lee H,Roh HS,Yoon JS. Assessment of quality of life and depression in Korean patients with Graves'ophthalmopathy[J].{H}Korean Journal of Ophthalmology,2010,(02):65-72.
  • 9Wiersinga WM. Quality of life in Graves'ophth-almopathy[J].{H}Best Practice and Research Clinical Endocrinology and Metablism,2012,(03):359-370.
  • 10Choi YJ,Lim HT,Lee SJ. Assessing Graves'ophthalmopathy-specific quality of life in Korean patients[J].Eye(Lond),2012,(04):544-551.

二级参考文献12

  • 1Petersen LA,Kriss JP,McDougall IR,et al.Prognostic factors in the radiotherapy of Graves'ophthalmopathy[J].Int J Radiat Oncol Biol,1990,19(2):259-264.
  • 2Olivotto IA,Ludgate CM,Allen LH,et al.Supervoltage radiotherapy for Graves'ophthalmopathy:CCABC technique and results[J].Int J Radiat Biol Phys,1985,1 1(12):2085-2090.
  • 3Marcocci C,Balmena L,Panicucci M,et al.Orbital cobah irradiation combined with retrobulbar or systemic corticosteroids for Graves' ophthalmopathy:a comparative study[J].Clin Endocrinol(Oxf),1987,27(1):33-42.
  • 4Prummel MF,Mourits MP,Blank L,et al.Randomized doubleblind trial of prednisone versus radiotherapy in Graves'ophthalmopathy[J].Lancet,1993,342(8877):949-954.
  • 5Mourits MP,van kempen-Harteveld ML,Garcia MB,et al.Radiotherapy for Graves'orbitopathy:randomised placebo-controlled study[1].Lancet,2000,355(9214):1505-1509.
  • 6Prummel MF,Terwee CB,Gerding MN,et al.A randomized controlled trial of orbital radiotherapy versus sham irradiation in patients with mild Graves' ophthalmopathy[J].J Clin Endocfinol Metab,2004,89(1):15-20.
  • 7Gorman CA,Garrity JA,Fatourechi V,et al.Aprospective,randomized,double-blind,placebo-controlled study of orbital radiotherapy for Graves' ophthalmopathy[J].Ophthalmology,2001,108:1523-1534.
  • 8Banalena L,Marcocci C,Pinchera A,et al.Orbital Radiotherapy for Graves' Ophthalmopathy[J].J Clin Endocrinol Metab,2004,89(1):13-14.
  • 9Bartalena L.Orbital radiation therapy and Graves' ophthalmopathy[J].Ophthalmology,2003,110(3):452-453.
  • 10Kahaly GJ,Rosler HP,Pitz S,etal.Low-versus high-dose radiotherapy for Graves' ophthalmopathy:a randomized,single blind trial[J].J Clin Endocrinol Metab,2000,85(1):102-108.

共引文献7

同被引文献16

引证文献2

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部